Antisense oligonucleotides (ASOs) can predictably alter RNA processing and control protein expression; however, challenges in the delivery of these therapeutics to specific tissues, poor cellular uptake, and endosomal escape have impeded progress in translating these agents into the clinic. Spherical nucleic acids (SNAs) are nanoparticles with a DNA external shell and a hydrophobic core that arise from the self-assembly of ASO strands conjugated to hydrophobic polymers. SNAs have recently shown significant promise as vehicles for improving the efficacy of ASO cellular uptake and gene silencing. However, to date, no studies have investigated the effect of the hydrophobic polymer sequence on the biological properties of SNAs. In this study, we created a library of ASO conjugates by covalently attaching polymers with linear or branched [dodecanediol phosphate] units and systematically varying polymer sequence and composition. We show that these parameters can significantly impact encapsulation efficiency, gene silencing activity, SNA stability, and cellular uptake, thus outlining optimized polymer architectures for gene silencing.
Get full access to this article
View all access options for this article.
References
1.
CrookeST, LiangX-H, BakerBF and Crooke.RM (2021). Antisense technology: a review. J Biol Chem, 296:100416.
2.
KhvorovaA and WattsJK. (2017). The chemical evolution of oligonucleotide therapies of clinical utility. Nat Biotechnol, 35:238–248.
3.
FlorPJ and NeumannI. (2010). In: Encyclopedia of Psychopharmacology. Stolerman IP, ed. Springer Berlin Heidelberg, Berlin, Heidelberg, pp. 277–278.
4.
PrakashTP and BhatB. (2007). 2′-Modified oligonucleotides for antisense therapeutics. Curr Top Med Chem, 7:641–649.
5.
ShenX and CoreyDR. (2018). Chemistry, mechanism and clinical status of antisense oligonucleotides and duplex RNAs. Nucl Acids Res, 46:1584–1600.
6.
AokiY and WoodMJ. (2021). Emerging oligonucleotide therapeutics for rare neuromuscular diseases. J Neuromusc Dis, 8:869–884.
7.
FakihHH, KatolikA, Malek-AdamianE, FakhouryJJ, KavianiS, DamhaMJ and SleimanHF. (2021). Design and enhanced gene silencing activity of spherical 2′-fluoroarabinose nucleic acids (FANA-SNAs). Chem Sci, 12:2993–3003.
8.
KuijperEC, BergsmaAJ, PijnappelWP and Aartsma-RusA. (2021). Opportunities and challenges for antisense oligonucleotide therapies. J Inherit Metab Dis, 44:72–87.
9.
DowlerT, BergeronD, TedeschiA-L, PaquetL, FerrariN and DamhaMJ. (2006). Improvements in siRNA properties mediated by 2′-deoxy-2′-fluoro-β-D-arabinonucleic acid (FANA). Nucl Acids Res, 34:1669–1675.
10.
IstrateA, KatolikA, IstrateA and LeumannCJ. (2017). 2′ β-fluoro-tricyclo nucleic acids (2′ F-tc-ANA): thermal duplex stability, structural studies, and RNase H activation. Chem A Eur J, 23:10310–10318.
BangaRJ, ChernyakN, NarayanSP, NguyenST and MirkinCA. (2014). Liposomal spherical nucleic acids. J Am Chem Soc, 136:9866–9869.
17.
CutlerJI, AuyeungE and MirkinCA. (2012). Spherical nucleic acids. J Am Chem Soc, 134:1376–1391.
18.
GulumkarV, AarelaA, MoisioO, RahkilaJ, TahtinenV, LeimuL, KorsoffN, KorhonenH, Poijarvi-VirtaP and MikkolaS. (2021). Controlled monofunctionalization of molecular spherical nucleic acids on a Buckminster fullerene core. Bioconjug Chem, 32:1130–1138.
19.
SamantaD, EbrahimiSB, KusmierzCD, ChengHF and MirkinCA. (2020). Protein spherical nucleic acids for live-cell chemical analysis. J Am Chem Soc, 142:13350–13355.
LiH, ZhangB, LuX, TanX, JiaF, XiaoY, ChengZ, LiY, SilvaDO and SchrekkerHS. (2018). Molecular spherical nucleic acids. Proc Natl Acad Sci U S A, 115:4340–4344.
24.
AltintasO and Barner-KowollikC. (2012). Single chain folding of synthetic polymers by covalent and non-covalent interactions: current status and future perspectives. Macromol Rapid Commun, 33:958–971.
25.
EdwardsonTG, CarneiroKM, SerpellCJ and SleimanHF. (2014). An efficient and modular route to sequence-defined polymers appended to DNA. Angew Chem, 126:4655–4659.
26.
BousmailD, AmreinL, FakhouryJJ, FakihHH, HsuJC, PanasciL and SleimanHF. (2017). Precision spherical nucleic acids for delivery of anticancer drugs. Chem Sci, 8:6218–6229.
27.
BousmailD, ChidchobP and SleimanHF. (2018). Cyanine-mediated DNA nanofiber growth with controlled dimensionality. J Am Chem Soc, 140:9518–9530.
28.
DoreMD, TrinhT, ZormanM, de RochambeauD, PlatnichCM, XuP, LuoX, RemingtonJM, ToaderV and CosaG. (2021). Thermosetting supramolecular polymerization of compartmentalized DNA fibers with stereo sequence and length control. Chem, 7:2395–2414.
29.
DeleaveyGF and DamhaMJ. (2012). Designing chemically modified oligonucleotides for targeted gene silencing. Chem Biol, 19:937–954.
30.
ZimmermannJ, KwakM, MusserAJ and HerrmannA. (2011). Bioconjugation Protocols. Springer, New York, Dordrecht, Heidelberg, London, pp. 239–266.
31.
AstakhovaK and BukhariSA. (2020). Nucleic Acid Detection and Structural Investigations. Springer, New York, United States.
32.
ChidchobP, EdwardsonTG, SerpellCJ and SleimanHF. (2016). Synergy of two assembly languages in DNA nanostructures: self-assembly of sequence-defined polymers on DNA cages. J Am Chem Soc, 138:4416–4425.
33.
de RochambeauD, SunY, BarlogM, BazziHS and HFSleiman. (2018). Modular strategy to expand the chemical diversity of DNA and sequence-controlled polymers. J Organ Chem, 83:9774–9786.
34.
DoreMD, FakhouryJJ, LacroixA and SleimanHF. (2018). Templated synthesis of spherical RNA nanoparticles with gene silencing activity. Chem Commun, 54:11296–11299.
35.
FakihHH, FakhouryJJ, BousmailD and SleimanHF. (2019). Minimalist design of a stimuli-responsive spherical nucleic acid for conditional delivery of oligonucleotide therapeutics. ACS Appl Mater Interface, 11:13912–13920.
36.
HuY, BebbG, TanS, NgR, YanH, SartorJR, MayerLD and BallyMB. (2004). Antitumor efficacy of oblimersen Bcl-2 antisense oligonucleotide alone and in combination with vinorelbine in xenograft models of human non–small cell lung cancer. Clin Cancer Res, 10:7662–7670.
37.
PatelS and PlayerMR. (2008). Small-molecule inhibitors of the p53-HDM2 interaction for the treatment of cancer. Exp Opin Invest Drugs, 17:1865–1882.
38.
TsuiP, RubensteinM and GuinanP. (2004). Synergistic effects of combination therapy employing antisense oligonucleotides with traditional chemotherapeutics in the PC-3 prostate cancer model. Med Oncol, 21:339–348.
39.
KeW, LuN, AA-JapirWMM, ZhouQ, XiL, WangY, DuttaD, ZhouM, PanY and GeZ. (2020). Length effect of stimuli-responsive block copolymer prodrug filomicelles on drug delivery efficiency. J Control Release, 318:67–77.
40.
ZhangZ, LiuC, LiC, WuW and Jiang.X (2019). Shape effects of cylindrical versus spherical unimolecular polymer nanomaterials on in vitro and in vivo behaviors. Research, 2019:2391486.
41.
ZhangZ, ZhaoJ, LiC, WuW and JiangX. (2019). Length effects of cylindrical polymer brushes on their in vitro and in vivo properties. Biomater Sci, 7:5124–5131.
42.
Lacroix AlE Vengut-Climent, de RochambeauD and SleimanHF. (2019). Uptake and fate of fluorescently labeled DNA nanostructures in cellular environments: a cautionary tale. ACS Central Sci, 5:882–891.
43.
MalmoJ, SørgårdH, VårumKM and StrandSP. (2012). siRNA delivery with chitosan nanoparticles: molecular properties favoring efficient gene silencing. J Control Release, 158:261–268.
44.
Choi K-m, KwonIC and AhnHJ. (2013). Self-assembled amphiphilic DNA-cholesterol/DNA-peptide hybrid duplexes with liposome-like structure for doxorubicin delivery. Biomaterials, 34:4183–4190.
45.
KolishettiN, DharS, ValenciaPM, LinLQ, KarnikR, LippardSJ, LangerR and FarokhzadOC. (2010). Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A, 107:17939–17944.
46.
PokholenkoO, GissotA, VialetB, BathanyK, ThiéryA and BarthélémyP. (2013). Lipid oligonucleotide conjugates as responsive nanomaterials for drug delivery. J Mater Chem B, 1:5329–5334.
47.
RosiNL, GiljohannDA, ThaxtonCS, Lytton-JeanAK, HanMS and MirkinCA. (2006). Oligonucleotide-modified gold nanoparticles for intracellular gene regulation. Science, 312:1027–1030.
48.
ZhuG, ZhengJ, SongE, DonovanM, ZhangK, LiuC and TanW. (2013). Self-assembled, aptamer-tethered DNA nanotrains for targeted transport of molecular drugs in cancer theranostics. Proc Natl Acad Sci U S A, 110:7998–8003.
49.
SongY, SongW, LanX, CaiW and Jiang.D (2022). Spherical nucleic acids: organized nucleotide aggregates as versatile nanomedicine. Aggregate, 3:e120.
50.
MeckesB, BangaRJ, NguyenST and Mirkin.CA (2018). Enhancing the stability and immunomodulatory activity of liposomal spherical nucleic acids through lipid-tail DNA modifications. Small, 14:1702909.
KimC-J, KimG-H, JeongEH, LeeH and ParkS-J. (2021). The core composition of DNA block copolymer micelles dictates DNA hybridization properties, nuclease stabilities, and cellular uptake efficiencies. Nanoscale, 13:13758–13763.
53.
BarbonSM, TruongNP, ElliottAG, CooperMA, DavisTP, WhittakerMR, HawkerCJ and AnastasakiA. (2020). Elucidating the effect of sequence and degree of polymerization on antimicrobial properties for block copolymers. Polymer Chem, 11:84–90.
54.
FröhlichT, EdingerD, KlägerR, TroiberC, SalcherE, BadgujarN, MartinI, SchaffertD, CengizerogluA and HadwigerP. (2012). Structure–activity relationships of siRNA carriers based on sequence-defined oligo (ethane amino) amides. J Control Release, 160:532–541.
MiyakeH, ChiKN and GleaveME. (2000). Antisense TRPM-2 oligodeoxynucleotides chemosensitize human androgen-independent PC-3 prostate cancer cells both in vitro and in vivo. Clin Cancer Res, 6:1655–1663.
57.
MiyakeH, HaraI, KamidonoS and GleaveME. (2001). Synergistic chemsensitization and inhibition of tumor growth and metastasis by the antisense oligodeoxynucleotide targeting clusterin gene in a human bladder cancer model. Clin Cancer Res, 7:4245–4252.
58.
ZellwegerT, MiyakeH, JulyLV, AkbariM, KiyamaS and GleaveME. (2001). Chemosensitization of human renal cell cancer using antisense oligonucleotides targeting the antiapoptotic gene clusterin. Neoplasia, 3:360–367.
59.
DeleaveyGF and DamhaMJ. (2012). Designing chemically modified oligonucleotides for targeted gene silencing. Chem Biol, 19:937–954.
60.
MinK-L, ViazovkinaE, GalarneauA, ParniakMA and DamhaMJ. (2002). Oligonucleotides comprised of alternating 2′-Deoxy-2′-fluoro-β-d-arabinonucleosides and d-2′-deoxyribonucleosides (2′ F-ANA/DNA ‘Altimers’) induce efficient RNA cleavage mediated by RNase H. Bioorgan Med Chem Letters, 12:2651–2654.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
